Search Results 521-530 of 2975 for 搜索引擎在线咨询邮箱：lgooxc@hotmail.com
This is a 52-week open-label study to evaluate the safety and tolerability of ADS-5102 oral capsules, an extended release formulation of amantadine, in ...
Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation eligibility.
Collaborators. Dr. Hawse is involved in ongoing research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators. Breast cancer.
The purpose of this study is to determine the overall survival of patients treated with Vigil versus gemcitabine/docetaxel. Participation eligibility.
Dr. Kita and his team in the Allergic Diseases Lab at Mayo Clinic work with numerous other investigators to harness the power of collaboration to advance ...
Type: Fellowship; Duration: 2 years; School: Graduate Medical Education; Specialty: Pediatric & Adolescent Medicine, Physical Medicine & ...
Phase 1-2 dose escalation randomized study in patients with intermediate or high risk myelodysplastic syndromes (MDS) or acute myelogenous leukemia (AML). The ...
Mayo Clinic researcher Steve G. Langer, Ph.D., explores tools for research analytics to be used in radiology and other areas.
Mayo Clinic College of Medicine and Science works to create an inclusive learning environment for everyone.
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.